Navigation Links
Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
Date:4/22/2008

enced patients were randomized to

receive 12 weeks of nitazoxanide followed by either the dual regimen

(n=12) or the triple regimen (n=12) for 36 weeks. Patients received

peginterferon alfa-2a (Pegasys(R), Hoffman LaRoche) 180 micrograms once

per week; nitazoxanide was administered as one 500 mg tablet twice

daily; and ribavirin (Copegus(R), Hoffman LaRoche) was administered as

1,000 or 1,200 mg daily according to body weight. Analysis of data was

by intention to treat.

In treatment-naive patients, combination therapy with nitazoxanide plus

SOC resulted in a SVR24 rate of 79%, compared with 50% for those

treated with SOC without nitazoxanide (P=0.023). When nitazoxanide was

combined with peginterferon alone, the observed SVR24 rate in this

group was 61%. In 24 treatment-experienced patients, the addition of

nitazoxanide to SOC for 36 weeks resulted in a 25% rate of SVR,

compared with 8% when nitazoxanide was combined with peginterferon

alone. The patients treated with nitazoxanide experienced no more side

effects than patients who received the SOC.

Interim results of this trial were presented at the 58th Annual Meeting

of the American Association for the Study of Liver Diseases (AASLD) in

Boston, MA.(1)

-- A poster presentation, titled "Evaluation of a 4-week Lead-in Phase

With Nitazoxanide Prior to Nitazoxanide+Peginterferon in Treating

Chronic Hepatitis C," demonstrated that reducing a nitazoxanide lead-in

phase from 12 to 4 weeks, followed by the addition of SOC therapy, does

not compromise virologic response rates in a patient population with

different genotypes, predominately genotype 4.

Replicon studies and an early clinical experience (unpublished)

indicated that treatment with nitazoxanide alone prior to adding

<
'/>"/>
SOURCE Romark Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Romark Laboratories Raises $18 Million in Institutional Financing
3. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... -- Henry Schein, Inc. (NASDAQ: HSIC ), the ... to office-based dental, animal health and medical practitioners, announced ... Inc., a leading full-service provider of dental consumables, implants ... into Japan , the world,s 2 ... the number of countries in which the Company operates. ...
(Date:10/18/2014)... 18, 2014  In a policy paper ... the nation,s largest lesbian, gay, bisexual and transgender ... of Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP is ... prevent the spread of a disease or infection ... name anti-HIV drug combination currently approved for PrEP, ...
(Date:10/17/2014)... 17, 2014  Training market researchers to spot ... factor in today,s highly competitive global marketplace. As ... that effectively and efficiently produce high performing analysts, ... Effective training programs can help ... from internal clients by developing analysts who can ...
Breaking Medicine Technology:Henry Schein Enters Japan With Investment in Iwase Dental Supply 2Henry Schein Enters Japan With Investment in Iwase Dental Supply 3Henry Schein Enters Japan With Investment in Iwase Dental Supply 4Henry Schein Enters Japan With Investment in Iwase Dental Supply 5HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2
... LLC today announced the appointment of Erica L. Mann as ... business based in Morristown, NJ, USA, with operations in more ... million.  Ms. Mann also becomes a member of the Bayer ... 14, 2011. Ms. Mann most recently served as ...
... NEW YORK, Feb. 22, 2011 Reportlinker.com announces ... in its catalogue: North American ... This research covers the state ... and restraints for growth, key trends, and end-user ...
Cached Medicine Technology:Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division 2Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division 3
(Date:10/19/2014)... (PRWEB) October 20, 2014 The ... iPage ( http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the ... excellent platforms for those who want to buy ... same time. , The IT manager of Top10BestSEOHosting.com ... the most recommended suppliers for everyone. A lot ...
(Date:10/19/2014)... York (PRWEB) October 19, 2014 Dr. ... Population Fund, welcomes news of a ceasefire agreement that ... more than 200 girls who were kidnapped from the ... have languished in captivity long enough, and it is ... and communities," stated Dr. Osotimehin. , "We owe it ...
(Date:10/19/2014)... October 20, 2014 Having been working in ... good knowledge of customer needs. According to James, one of ... with dazzling sequins, or with high-low skirts that add beauty ... huge demand. Recently, LunaDress has unveiled its new selection of ... fact, the company’s brand new items are available in over ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that ... announced its latest designs of 2014 mother of ... elegant outfits are offered with big discounts, up to ... October 30 can enjoy this special offer. , ... it has become one of the leading brands in ...
(Date:10/19/2014)... Charlotte, NC (PRWEB) October 19, 2014 ... muscle building program has just been released to ... throughout the online body building and fitness community. ... the attention of DietsAndFitnessGuides.com's Vin Delmonico prompting an ... the experience of hitting what is commonly known ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2
... Cediranib reduces tissue swelling better than steroids, ... -- Anti-angiogenesis drugs reduce edema (swelling of brain ... a new study suggests. , Anti-angiogenesis drugs prevent ... need to grow, the researchers pointed out. , ...
... , Big Boi, Asher Roth, Keri Hilson, Perez ... National Campaign with the Kaiser Family Foundation, Planned Parenthood and Others ... Outreach One in Two Sexually-Active Americans Contracts ... April 2 MTV and the ...
... through a long period of relative dormancy after a series of ... the U.S. Food and Drug Administration approved them for use in ... Zeff, MD comments on why he feels the FDA’s decision was ... ...
... Stylist, Lauri Eisenberg, Offers Her No-Sweat Fashion Tips ,So Excessive Perspiration ... ... April 2, 2009 -- If you,d never consider wearing silk or ... marks, you pick patterns over solids to hide the issue, or ...
... DUSSELDORF, Germany, April 2 In the first,quarter of ... total sales figure of EUR237.3m (Q1 2008: EUR239.1m) almost ... in the world economy. In,the core business, however, sales ... EUR228.7m , The operating result ...
... to deploy HealtheTrax(TM) for Sleep Services of AmericaELKRIDGE, ... thought leader in health information technologies, today announced ... its HealtheTrax(TM) software service with Sleep Services of ... CPAP therapy in Maryland. HealtheTrax(TM) is the ...
Cached Medicine News:Health News:Drug Improves Survival in Mice With Brain Tumors 2Health News:MTV Unwraps GYT: Get Yourself Tested 2Health News:MTV Unwraps GYT: Get Yourself Tested 3Health News:MTV Unwraps GYT: Get Yourself Tested 4Health News:MTV Unwraps GYT: Get Yourself Tested 5Health News:MTV Unwraps GYT: Get Yourself Tested 6Health News:MTV Unwraps GYT: Get Yourself Tested 7Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 2Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 3Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 4Health News:Don't Sacrifice Style Because of Sweat 2Health News:Don't Sacrifice Style Because of Sweat 3Health News:Don't Sacrifice Style Because of Sweat 4Health News:Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed 2Health News:Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed 3Health News:Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed 4Health News:New Virtual Health Assistant Introduced 2Health News:New Virtual Health Assistant Introduced 3
Bipolar forceps...
... in vitro Nucleic Acid Hybridization ... Microplate Chemiluminescence for the Qualitative ... Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 and ... High-Risk Groups in Cervical Specimens: ...
... radiation protection-0.62mm (+/- .05)Pb lead glass equivelant ... their level of protection, they are incredibly ... on your bridge while hugging your face ... corrective lenses, you can order Leaded Eyeglasses ...
... time in the world, there is a now ... diagnose VVC in female patients. CanDia5® is a ... the Candida antigens almost instantaneously (within 5 minutes) ... There is no similar POC product for VVC ...
Medicine Products: